Bladder Cancer Causes
Bladder Cancer Causes
Bladder cancer has one of the clearest sets of causes among solid tumours, which is unusual and useful: the bladder is a reservoir for whatever the body is excreting, so carcinogens that enter the bloodstream and are cleared by the kidney sit in contact with the lining for hours. Smoking is the largest single contributor, a defined group of industrial chemicals is the second, and chronic irritation produces a different tumour type altogether.
Smoking
Smoking is the largest single contributing factor in bladder cancer, and the mechanism explains why. Tobacco smoke contains aromatic amines and other carcinogens that are absorbed into the blood, processed by the liver, and then concentrated by the kidney into urine. Because the bladder stores that urine, the lining sits in contact with the concentrated carcinogen for hours at a time — a pattern of exposure quite unlike that of the lung, where the smoke is diluted by each breath.
Two consequences follow for anyone weighing their own risk. The first is that the relevant exposure is cumulative and measured in pack-years rather than in whether one currently smokes, and that the risk falls after stopping but does not return to that of a never-smoker. The second is that smoking also makes the disease more likely to behave aggressively, which is a separate effect from causing it.
The practical implication is that a smoking history changes how a symptom is interpreted. Visible blood in the urine in a person who has smoked deserves investigation at any age, and a persistent finding on urine testing in a former smoker is not made benign by the fact that the person stopped — the exposure has already happened. This is one of the few places in this cluster where a history itself, rather than a finding, changes the next step.
Occupational exposure
The second established cause is a group of industrial chemicals, and its history is unusually well documented because the link was noticed in workers rather than in the laboratory. The relevant substances are aromatic amines, including benzidine and 2-naphthylamine. These are metabolised in the body into reactive products that bind DNA, and the bladder lining is precisely where they are concentrated and then held in contact with the tissue for hours. The occupations in which exposure has been documented are specific:
- Dye and pigment manufacture — the industry in which the association was first described, and the setting in which benzidine and 2-naphthylamine have been most studied.
- Rubber and tyre production — where these chemicals were used as antioxidants, and where several aromatic amine intermediates are handled.
- Leather tanning and finishing — recognised early, and one of the reasons leather work appears on occupational exposure lists.
- Painting and printing — including the manufacture of inks and dyes, and exposure to solvents as well as pigments.
- Aluminium production and certain metal-working processes; polycyclic aromatic hydrocarbon exposure in coke production and coal gasification belongs to the same group.
- Diesel exhaust and combustion products in a range of heavy industries.
- Arsenic in drinking water in some regions — an environmental rather than an occupational exposure, but it belongs in the same history, because arsenic is an established bladder carcinogen.
- Hairdressing and long-term work with hair dyes — studied for decades, though the evidence is not as strong as for the industries above; occupational exposure as a hairdresser is therefore treated as a probable rather than an established risk. Occasional personal use of hair dye is a different question, and is dealt with below.
Two features of occupational bladder cancer matter in practice. The incubation period is long — typically decades between exposure and diagnosis — so a patient may have left the industry long before the tumour appears, and the connection is easily missed unless the occupational history is asked for. And the risk is not confined to current workers: because these exposures have been regulated only gradually, a significant share of cases arises in people whose exposure ended years ago.
Because the risk is cumulative, the number of years exposed and the level of protection matter more than the bare fact of having worked in the industry at some point. In someone with an occupational history, an abnormal urine test is worth working up rather than simply repeating. An occupational history is therefore worth volunteering at the first consultation rather than waiting to be asked — it is information only the patient can provide, and it changes how a urinary symptom is judged.
Chronic irritation and a different tumour type
When the bladder lining is irritated continuously for years, the urothelium can transform into a different kind of epithelium — a change called squamous metaplasia — and the cancer that arises from it is squamous cell carcinoma rather than urothelial carcinoma. The triggers are all forms of chronic irritation:
- Long-term catheterisation — particularly in patients with spinal cord injury or a neurogenic bladder, where catheters are often needed for decades.
- Recurrent or chronic urinary infection — including the inflammation associated with bladder stones and long-standing cystitis.
- Schistosomiasis — infection with Schistosoma haematobium, which deposits eggs in the bladder wall and is the reason squamous cell carcinoma is common in parts of Africa and the Middle East.
- Long-standing bladder diverticula or an untreated obstruction — which leave urine stagnating in contact with the lining.
This matters because the tumour is treated differently. Squamous cell carcinoma does not respond to the intravesical drugs used for urothelial disease, and it tends to be diagnosed later, because in patients with long-term catheters blood in the urine is easily attributed to the catheter or to infection. For a patient with a spinal cord injury or a long history of catheterisation, new bleeding is a reason for cystoscopy rather than part of the usual background.
Genes and family history
Bladder cancer is not primarily a hereditary disease, but inherited factors contribute in a minority of cases and are worth recognising because they change what is offered to relatives:
- A first-degree relative with bladder cancer — associated with an increase in risk of roughly one and a half to two times that of the general population. Part of that clustering reflects shared smoking and shared environment rather than inheritance alone, and the increase on its own is not large enough to justify a separate screening programme.
- Lynch syndrome — an inherited mismatch repair defect that predisposes to cancers of the colon, endometrium, ovary and upper urinary tract as well as the bladder. It changes surveillance for the whole family and is the reason a young patient or one with several family cancers should be assessed for it.
- Inherited differences in carcinogen metabolism — variations in the enzymes that activate or detoxify tobacco and industrial carcinogens, including the N-acetyltransferase and glutathione S-transferase families, which help explain why two people with similar exposure can have different outcomes.
- Previous pelvic radiotherapy or cyclophosphamide treatment — a treatment-related rather than inherited risk, but one that should be part of the history.
Where there is a strong family history — several relatives with bladder or upper urinary tract cancer, or a known Lynch syndrome diagnosis — a genetics consultation is worth arranging, because it changes surveillance for relatives and not only the patient. For most other patients the useful action is attention to exposures that can still be modified and to symptoms that should prompt assessment. A family history is also worth not over-reading: most people with bladder cancer have none, and having none does not change the rule that visible blood in the urine needs to be examined.
What does not cause it
Several widely repeated beliefs about bladder cancer are not supported, and clearing them up prevents unnecessary worry:
- Coffee — studied extensively, and not established as a cause.
- Artificial sweeteners — the early signal came from animal studies at doses far above human intake; later human studies have not confirmed a risk at usual consumption.
- Alcohol — not an established cause of bladder cancer, unlike its established role in several other tumours.
- Hair dye used at home — the occupational exposure in hairdressing is a recognised industrial risk, but personal and occasional use of hair dye has not been established as a cause.
- Urinary infection on its own — a single or occasional infection is not a cause; it is prolonged, continuous irritation that is associated with the squamous type.
- Benign Prostatic Hyperplasia or kidney stones — these cause symptoms that can mimic the disease and may cause bleeding, but they are not causes of it.
- Spicy food and carbonated drinks — these can aggravate frequency and urgency in a bladder that is already irritated, but there is no evidence that they cause the disease. A food that makes a symptom worse is not evidence that it caused the tumour.
- Blood group and other constitutional traits — studied without reaching a consistent conclusion, and not something a person can act on; neither is a reason for or against investigation.
The reason to list these is that they are the explanations patients most often offer themselves, and these self-explanations are the causes of delay to diagnosis.Blood in your urine cannot be explained by drinking coffee or using artificial sweeteners, and the next steps you should take won’t change based on which one you suspect is the cause.What does change it is smoking, occupational exposure and chronic catheterisation — the three items on this list that are genuinely relevant.
Who is at higher risk
The groups for whom a urinary symptom deserves a lower threshold for investigation:
Current or former smokers, and particularly those with a substantial pack-year history
Anyone with a documented occupational exposure to aromatic amines, dyes, rubber or combustion products
Patients with long-term catheters, a neurogenic bladder or a spinal cord injury
Anyone who has had pelvic radiotherapy or cyclophosphamide treatment
Those with a first-degree relative with bladder cancer, or a known Lynch syndrome diagnosis
Anyone with a previous bladder or upper urinary tract urothelial tumour, since the lining remains at risk
Older age and male sex — age is the most consistent factor of all, and men are affected roughly three to four times as often as women; neither can be modified, which is why neither replaces attention to symptoms
Two points that need to be clarified: being in one of these groups does not mean a person will develop the disease, and most do not; and not being in any of them does not remove the possibility, because a substantial minority of patients have no identifiable exposure — which is why visible blood in the urine is investigated on its own merits. For anyone above, the useful action is prompt assessment rather than giving it time. The role and limits of urinary testing are set out on the prevention page.